Cargando…
Erratum to: Objective Biomarkers for Clinical Relapse in Multiple Sclerosis: A Metabolomics Approach
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667265/ https://www.ncbi.nlm.nih.gov/pubmed/34913033 http://dx.doi.org/10.1093/braincomms/fcab283 |
Ejemplares similares
-
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach
por: Yeo, Tianrong, et al.
Publicado: (2021) -
Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study
por: Ordoñez-Boschetti, Laura, et al.
Publicado: (2015) -
Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group
por: Fazekas, Franz
Publicado: (2013) -
Erratum to: Identification of more objective biomarkers for Blood-Stasis syndrome diagnosis
por: Liao, Jiangquan, et al.
Publicado: (2016) -
Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)